Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 30,000 shares at $53.13 ($1.6M) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Scheduled sale ($1.6M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |
| SWTX | SELL | 2024-06-05 | $1.6M | — | Filing → |